You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
香雪製藥(300147.SZ):終止參與設立花城人壽保險
格隆匯 03-18 19:02

格隆匯3月18日丨香雪製藥(300147.SZ)公吿稱,公司第七屆董事會第五次會議、2016年第四次臨時股東大會審議通過了《關於公司參與發起設立花城人壽保險股份有限公司的議案》,同意公司與廣東海印集團股份有限公司、金髮科技股份有限公司等6家企業聯合發起設立花城人壽保險股份有限公司(簡稱“花城人壽保險”),註冊資本10億元,公司擬出資1.6億元,認購花城人壽保險16%股份。

花城人壽保險籌備組推動了籌建工作,於2016年12月收到中國保險監督管理委員會關於發起設立花城人壽保險的《行政許可申請材料收文回執》(文號:保監許收字【2016】415號)。近日經花城人壽保險籌備組及各發起人協商,綜合考慮近年宏觀經濟環境及金融政策變化,一致決定終止籌備花城人壽保險,籌備期間產生的費用由各發起人根據《花城人壽保險股份有限公司發起人協議書》的約定按認繳出資比例分擔。

該次終止事項有利於公司進一步聚焦主營業務的發展,整合優化資產結構及資源配置,符合公司實際經營和未來發展需要,不會對公司的財務狀況及日常經營產生影響。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account